Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Vaccine|December 31, 2017
Development of an FHbp-CTB holotoxin-like chimera and the elicitation of bactericidal antibodies against serogroup B Neisseria meningitidisGregory A Price, Margaret C BashCurrent Infectious Disease Reports|March 10, 2006
Extragenital manifestations of Neisseria gonorrhoeaeSteven E Spencer, Margaret C BashVaccine|September 11, 2013
Vaccines against gonorrhea: current status and future challengesAnn E Jerse, Margaret C Bash, Michael W RussellThe Journal of Infectious Diseases|April 16, 2003
Porin variation among clinical isolates of Neisseria gonorrhoeae over a 10-year period, as determined by Por variable region typingDurrie L McKnew, Freyja Lynn, Jonathan M Zenilman, et al.Infection and Immunity|June 18, 2002
Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responsesDavid S Berry, Freyja Lynn, Che-Hung Lee, et al.Journal of Clinical Microbiology|April 9, 2005
por Variable-region typing by DNA probe hybridization is broadly applicable to epidemiologic studies of Neisseria gonorrhoeaeMargaret C Bash, Peixuan Zhu, Sunita Gulati, et al.BMC Evolutionary Biology|June 5, 2007
Distinguishing importation from diversification of quinolone-resistant Neisseria gonorrhoeae by molecular evolutionary analysisMarcos Pérez-Losada, Keith A Crandall, Margaret C Bash, et al.The Journal of Infectious Diseases|May 15, 2004
Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologiesJulie A Giles, Jason Falconio, Jeffrey D Yuenger, et al.Vaccine|February 11, 2020
Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strainsKathryn A Matthias, Alexandra Reveille, Kristie L Connolly, et al.Pageof 3